Articles | Volume 4, issue 1
https://doi.org/10.7150/jbji.29711
https://doi.org/10.7150/jbji.29711
Original full-length article
 | 
01 Jan 2019
Original full-length article |  | 01 Jan 2019

Determination of Tobramycin and Vancomycin Exposure Required to Eradicate Biofilms on Muscle and Bone Tissue In Vitro

Vajra Badha, Rex Moore, John Heffernan, Paulo Castaneda, Alex McLaren, and Derek Overstreet

Cited articles

Hall-Stoodley L, Stoodley P, Kathju S. et al. Towards diagnostic guidelines for biofilm-associated infections. FEMS Immunol Med Microbiol. 2012;65:127–145. doi:10.1111/j.1574-695X.2012.00968.x.
Costerton JW, Stewart PS, Greenberg EP. Bacterial Biofilms: A Common Cause of Persistent Infections. Science. 1999;284:1318–1322. doi:10.1126/science.284.5418.1318.
Donlan RM, Costerton JW. Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms. Clin Microbiol Rev. 2002;15:167–193. doi:10.1128/CMR.15.2.167-193.2002. [PMC free article]
Lewis K. Riddle of Biofilm Resistance. Antimicrob Agents Chemother. 2001;45:999–1007. doi:10.1128/AAC.45.4.999-1007.2001. [PMC free article]
Download